Redmile Group, LLC Bioventus Inc. Transaction History

Redmile Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.81 - $8.14 $1.38 Million - $6.21 Million	-763,189 Reduced 58.75%	535,950 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$6.54 - $9.08 $47,088 - $65,376	-7,200 Reduced 0.55%	1,299,139 $9.09 Million
Q2 2022 Aug 15, 2022	BUY	$6.82 - $13.82 $65,472 - $132,672	9,600 Added 0.74%	1,306,339 $8.91 Million
Q1 2022 May 16, 2022	SELL	$11.65 - $15.28 $330,860 - $433,952	-28,400 Reduced 2.14%	1,296,739 $18.3 Million
Q4 2021 Feb 14, 2022	SELL	$12.37 - $16.77 $2.04 Million - $2.76 Million	-164,717 Reduced 11.06%	1,325,139 $19.2 Million
Q3 2021 Nov 15, 2021	BUY	$13.7 - $17.25 $39,730 - $50,025	2,900 Added 0.2%	1,489,856 $21.1 Million
Q2 2021 Aug 16, 2021	SELL	$13.75 - $18.8 $179,355 - $245,227	-13,044 Reduced 0.87%	1,486,956 $26.2 Million
Q1 2021 May 17, 2021	BUY	$11.49 - $19.21 $17.2 Million - $28.8 Million	1,500,000 New	1,500,000 $22.9 Million

143

45.9M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $659M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.